Sandoz Group AG (SWX: SDZ)
Health Care · Pharmaceuticals · CH
CHF70.60
+1.26% today · +40.9% 1Y
Sandoz Group AG (SWX: SDZ) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $36.31B and employs 20,000 people.
Over the last twelve months the share price has gained 40.9%, trading between 45.79 and 75.90.
Tweenvest scores Sandoz Group AG across four factors: quality 73/100, value 41/100, growth 55/100, dividend 28/100. Its strongest factor is quality.
SDZ price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $36.31B
- Revenue (TTM)
- $11.68B
- P/E
- 58.76
- EPS
- 1.47
- Dividend yield
- 1.15%
- Beta (5Y)
- 0.46
- 52-week high
- CHF75.90
- 52-week low
- CHF45.79
- Avg volume (3M)
- —
- Shares outstanding
- 432.69M
- Employees
- 20,000
- Next earnings
- —
About Sandoz Group AG
Operating globally, Sandoz Group AG specializes in the development, production, and distribution of generic medications and biosimilar products. The company's portfolio includes the creation and sale of finished dosage forms for small molecule pharmaceuticals, often supplied to other entities. Sandoz is also a significant player in the biotechnology sector, providing protein-based products such as biosimilars and offering specialized manufacturing services within this field. Furthermore, it supplies anti-infective products, including active pharmaceutical ingredients (APIs) and intermediates, with a strong emphasis on antibiotics. Established in 1886, Sandoz maintains its headquarters in Rotkreuz, Switzerland.
- ISIN
- CH1243598427
- Founded
- 1886
- Listed since
- Oct 3, 2023
- Exchange
- SIX Swiss Exchange
- Currency
- CHF
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Sun Pharmaceutical Industries LimitedNSEI: SUNPHARMA | $43.63B | Rs1,760.00 | +0.01% |
| UCB SAENXTBR: UCB | $43.44B | €204.00 | +0.25% |
| Haleon plcLSE: HLN | $40.71B | £3.49 | +1.42% |
| Otsuka Holdings Co., Ltd.TSE: 4578 | $38.71B | ¥11,665.00 | -0.13% |
| Zoetis Inc.NYSE: ZTS | $30.91B | $75.21 | +0.53% |
| Daiichi Sankyo Company, LimitedTSE: 4568 | $30.16B | ¥2,623.00 | -3.17% |
| Astellas Pharma Inc.TSE: 4503 | $25.45B | ¥2,247.50 | -0.02% |
| Royalty Pharma plcNasdaqGS: RPRX | $25.35B | $57.15 | +0.39% |
Figures last refreshed Oct 11, 2026.